PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: quiz answers

Annex 9 - WHO

439 World Health OrganizationWHO Technical Report Series, No. 937, 2006 Annex 9 Additional guidance for organizations performing in vivo bioequivalence studiesIntroduction1. Scope2. Glossary 3. Organization and management 4. Computer systems Hardware Software Data management 5. Archive facilities 6. Premises 7. Clinical phase 8. Clinical laboratory 9. Personnel 10. Quality assurance 11. Ethics Independent ethics committee Informed consent 12.

441 Bioequivalence studies should be performed in compliance with the general regulatory requirements and recommendations on good practices as speci-

Fullscreen Download
Loading..

Tags:

  Annex 9, Annex, Bioequivalence

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Annex 9 - WHO

Documents from same domain

INVESTING IN HEALTH FOR ECONOMIC …

www.who.int

2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …

  Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development

WHO GOOD PRACTICES FOR PHARMACEUTICAL …

www.who.int

working document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories

  Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories

NORMES ET STANDARDS EN INFRASTRUCTURES …

www.who.int

normes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …

  Infrastructures

Heterotrophic Plate Count Measurement in …

www.who.int

World Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management

  Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization

Annex 3 WHO good manufacturing practices for ...

www.who.int

96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth

  Good, Practices

Annex 5 WHO good distribution practices for …

www.who.int

236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are

  Good, Practices, Pharmaceutical, Good distribution practices for, Distribution

Annex 2 WHO good practices for pharmaceutical …

www.who.int

71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms

  Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories

LABORATORY BIOSAFETY MANUAL - WHO

www.who.int

interim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003

  Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety

Mycobacteriology Laboratory Manual - WHO

www.who.int

Mycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …

  Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology

Laboratory Guidelines for enumerating CD4 T …

www.who.int

SEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia

  Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating

Related documents

INVESTIGATION OF BIOAVAILABILITY AND …

apps.who.int

1 MALAYSIAN GUIDELINES FOR THE CONDUCT OF BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES LOGO MINISTRY OF HEALTH, MALAYSIA Supported by Seminar on Clinical Trials and Bioequivalence Studies

  Investigation, Conduct, Bioequivalence, Bioavailability, Investigation of bioavailability and, The conduct of bioavailability and bioequivalence

GUIDELINES FOR BIOAVAILABILITY & …

www.cdsco.nic.in

GUIDELINES FOR BIOAVAILABILITY & BIOEQUIVALENCE STUDIES Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare,

  Guidelines, Bioequivalence, Bioavailability, Guidelines for bioavailability

Guideline on the Regulation of Therapeutic …

www.medsafe.govt.nz

Bioequivalence • • 1.1. Introduction Bioavailability is a key attribute of medicines used for systemic effects. It is defined as the rate and extent of absorption of the active ingredient in a medicine into systemic circulation.

  Bioequivalence

Demystifying FDA’s 505(b)(2) Drug Registration …

djaglobalpharma.com

1 October 2009 Demystifying FDA’s 505(b)(2) Drug Registration Process By Harriette L. Nadler, PhD and Damaris DeGraft-Johnson, RPh, MSc

  Drug, Process, Registration, Drug registration, Drug registration process

Handling of Reserve Samples in Pharmaceutical …

globalresearchonline.net

Int. J. Pharm. Sci. Rev. Res., 37(2), March – April 2016; Article No. 04, Pages: 27-29 ISSN 0976 – 044X

  Reserve, Pharmaceutical, Of reserve samples in pharmaceutical, Samples

Related search queries

INVESTIGATION OF BIOAVAILABILITY AND, THE CONDUCT OF BIOAVAILABILITY AND BIOEQUIVALENCE, Bioequivalence, GUIDELINES FOR BIOAVAILABILITY, 505(b)(2) Drug Registration, 505(b)(2) Drug Registration Process, Of Reserve Samples in Pharmaceutical